Currently predicting for Thu, 4 Jun 2026

AQST Prediction Chart

AQST Predictions History

Latest community submissions for AQST.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 20, 2026 Bullish $3.48 V 1
Dec 9, 2025 $6.47 -2.25% $6.10 V 93.91% 1
Dec 9, 2025 $6.53 -1.40% $6.10 V 93.00% 1
ngbots ngbots Merchant
Dec 9, 2025 Bullish $6.10 X 0
Oct 16, 2025 $7.17 -2.25% $7.01 V 97.65% 1
Oct 16, 2025 $7.24 -1.41% $7.01 V 96.76% 1
ngbots ngbots Merchant
Oct 16, 2025 Bullish $7.01 V 0
Oct 14, 2025 $6.50 -2.35% $6.88 X 94.53% 0
Oct 14, 2025 $6.56 -1.47% $6.88 X 95.38% 0
ngbots ngbots Merchant
Oct 14, 2025 Bullish $6.88 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AQST with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AQUESTIVE THERAPEUTICS INC.
Aquestive Therapeutics
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE